Global X Genomics & Biotechnology ETF
GNOM
GNOM
58 hedge funds and large institutions have $111M invested in Global X Genomics & Biotechnology ETF in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
Holders
58
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$54M | |
| 2 | +$4.22M | |
| 3 | +$2.43M | |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$1.11M |
| 5 |
OCM
One Capital Management
Westlake Village,
California
|
+$682K |
Top Sellers
| 1 | -$3.26M | |
| 2 | -$697K | |
| 3 | -$576K | |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$556K |
| 5 |
MML Investors Services
Springfield,
Massachusetts
|
-$540K |